A novel mutation in intron 1 of Wnt1 causes developmental loss of dopaminergic neurons in midbrain and ASD-like behaviors in rats

Ya‐Ping Tang, Yongyi Li, Mingwei Zhu, Wen‐Xiong Chen, Jing Luo, Xin Li, Yangyang Cao, Meng Zheng, Shanshan Ma, Zhilan Xiao, Yani Zhang, Linyan Jiang, Xiumin Wang, T. Tan, Xia Li, Qian Gong, Xiaoli Xiong, Jun Wang, Mingxi Tang, Mingtao LiResearch Square 2023 · DOI

Introduction

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with a strong genetic component. While over 1,000 risk genes have been identified, the precise mechanisms by which these genetic variations alter brain development remain largely unknown. This study investigates a novel mutation in the Wnt1 gene, a critical regulator of brain development, and its role in the pathogenesis of ASD.

Genetic Discovery and Molecular Mechanism

Researchers identified a homozygous mutation in intron 1 of the Wnt1 gene in a patient with ASD. Unlike mutations in coding regions (exons), this intronic mutation creates a "cryptic" splice donor site. This causes the cell to skip the first exon during protein synthesis, leading to a complete loss of WNT1 protein expression.

A Humanized Rat Model of ASD

To study the biological impact, the team used CRISPR-Cas9 to create a "humanized" rat model carrying this exact mutation. These mutant rats exhibited robust ASD-like behaviors, including:

  • Impaired Communication: Significantly fewer ultrasonic vocalizations (USV).
  • Social Deficits: A lack of preference for social novelty in the Three-Chamber Social Test.
  • Repetitive Behaviors: Increased repetitive rotations in open-field tests.

Neuroanatomical and Cellular Underpinnings

The most striking finding was a significant loss of dopaminergic (DAergic) neurons. Mutant rats showed a 49.8% reduction in dopamine neurons in the substantia nigra pars compacta (SNpc) and the ventral tegmental area (VTA), along with reduced dopamine fibers in the striatum.

Using single-cell RNA sequencing (scRNA-seq) on embryonic rat brains (E11.5), the researchers discovered that this loss stems from an early developmental "boundary shift." The pool of progenitor cells in the midbrain floor plate (which normally become dopamine neurons) shrank from 12.03% to 8.39%, while the neighboring hypothalamic pool expanded. This suggests that the Wnt1 mutation causes potential dopamine neurons to lose their identity during the embryonic stage, possibly driven by the up-regulation of the Notch signaling ligand Dlk1.

Therapeutic Potential of Dopamine Replacement

Interestingly, treating the mutant rats with L-dopa (a dopamine precursor) almost completely restored social novelty and vocal communication to wild-type levels. However, it did not alleviate repetitive behaviors. This indicates that while social deficits in this model are dopamine-dependent, repetitive behaviors likely involve other affected brain regions or circuits, such as the cerebellum or hypothalamus.

Conclusion

This research provides the first evidence that the developmental loss of midbrain dopaminergic neurons, driven by abnormal progenitor cell patterning, underlies the pathogenesis of a specific ASD subtype. The success of dopamine replacement therapy in rescuing social symptoms offers a promising translational path for patients with similar neurodevelopmental profiles, highlighting the importance of personalized medicine in treating ASD.

Summary updated

Abstract

<title>Abstract</title> Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders with a strong genetic liability. Despite extensive studies, however, the underlying pathogenic mechanism still remains elusive. In the present study, we identified a homozygous mutation in the intron 1 of Wnt1 via large-scale screening of ASD risk/causative genes and verified that this mutation created a new splicing donor site in the intron1, and consequently, a loss of WNT1 expression. Interestingly, humanized rat models harboring this mutation exhibited robust ASD-like behaviors including impaired ultrasonic vocalization (USV), decreased social interactions, and restricted and repetitive behaviors. Moreover, in the substantia nigra compacta (SNpc) and the ventral tegmental area (VTA) of mutant rats, dopaminergic (DAergic) neurons were dramatically lost, together with a comparable decrease in striatal DAergic fibers. Furthermore, using single-cell RNA sequencing, we demonstrated that the decreased DAergic neurons in these midbrain areas might attribute to a shift of the boundary of the local pool of progenitor cells from the hypothalamic floor plate to the midbrain floor plate during the early embryonic stage. Moreover, treatments of mutant rats with levodopa could attenuate the impaired USV and social interactions almost completely, but not the restricted and repetitive behaviors. Our results for the first time documented that the developmental loss of DAergic neurons in the midbrain underlies the pathogenesis of ASD, and that the abnormal progenitor cell patterning is a cellular underpinning for this developmental DAergic neuronal loss. Importantly, the effective dopamine therapy suggests a translational significance in the treatment of ASD.
BibTeX
@inproceedings{tang2023novel,
  author = {Ya‐Ping Tang and Yongyi Li and Mingwei Zhu and Wen‐Xiong Chen and Jing Luo and Xin Li and Yangyang Cao and Meng Zheng and Shanshan Ma and Zhilan Xiao and Yani Zhang and Linyan Jiang and Xiumin Wang and T. Tan and Xia Li and Qian Gong and Xiaoli Xiong and Jun Wang and Mingxi Tang and Mingtao Li},
  title = {{A novel mutation in intron 1 of Wnt1 causes developmental loss of dopaminergic neurons in midbrain and ASD-like behaviors in rats}},
  booktitle = {Research Square},
  year = {2023},
  doi = {10.21203/rs.3.rs-2537486/v1},
}
Figure